There are 2867 resources available
The impact of COVID-19 pandemic on cancer patients and early diagnosis - Time to act!
Presenter: Mark Lawler
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Clara Montagut Viladot
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
ER+ HER2 - advanced breast cancer
Presenter: Stephen Johnston
Session: Updates in the standard of care of metastatic breast cancer
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Alessandra Curioni
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
Acute myeloid leukaemia
Presenter: Lars Bullinger
Session: How diagnostic tools impact therapy of haematological malignancies
Resources:
Slides
Webcast
Uveal melanoma
Presenter: Sapna Patel
Session: Advances in non-cutaneous melanoma
Resources:
Slides
Webcast
Matching a molecular readout to a novel therapeutic
Presenter: Martijn Lolkema
Session: Using molecular data that impacts clinical practice
Resources:
Slides
Webcast
The role of molecular biology in defining new entities
Presenter: Inga-Marie Schaefer
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Slides
Webcast
LBA29 - Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
277O - The ReSPECT-GBM™ phase I/IIa trial of rhenium-186 nanoliposome (186RNL) in recurrent glioma via convection enhanced delivery (CED) and planned phase IIb trial
Presenter: Andrew Brenner
Session: Proffered Paper session: CNS tumours
Resources:
Abstract
Slides
Webcast